The report provides a detailed analysis essential for establishing a Clomipramine production plant. It encompasses all critical aspects necessary for Clomipramine production, including the cost of Clomipramine production, Clomipramine plant cost, Clomipramine production costs, and the overall Clomipramine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Clomipramine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Clomipramine is a tricyclic antidepressant that is mainly used in the medical and pharmaceutical sector. It is primarily used for the treatment and management of obsessive–compulsive disorder (OCD), where it helps reduce repetitive thoughts and compulsive behaviours. It works by affecting the balance of certain chemicals in the brain, especially serotonin and norepinephrine.
It is also used in managing depression, especially in patients who do not respond well to other antidepressant medicines. In addition, it also finds application in the treatment of panic disorders, chronic anxiety, and phobias, which helps improve emotional stability and daily functioning. In some cases, doctors use it for treating cataplexy in patients with narcolepsy, and for managing chronic pain or migraine when other treatments are not effective. It is often used in pain management and sleep-related disorders due to its effect on the nervous system. Additionally, it is also sometimes used in the treatment of cataplexy associated with narcolepsy, trichotillomania, premature ejaculation, and body dysmorphic disorder.
The market for Clomipramine is predominantly driven by its usage as a medication to treat mental health conditions, which boosts its demand in the medical and pharmaceutical sectors. Its application as an FDA-approved drug for the treatment of obsessive-compulsive disorder significantly drives its demand in the pharmaceutical industry.
Its application as a drug in the treatment of depression, panic attacks, and chronic anxiety also strengthens its demand in the mental healthcare sector. Its demand as an important drug in psychiatric care and clinical research related to mood and anxiety disorders also promotes its market expansion. Factors, including the cost and supply of key raw materials like 3-chloroiminodibenzyl and dimethylaminopropyl chloride, regulatory compliance, intellectual property considerations, and adherence to production quality standards, significantly impact Industrial Clomipramine procurement. Furthermore, process efficiency, supplier credibility, and global distribution capabilities also affect its procurement strategies.
Raw Material for Clomipramine Production
According to the Clomipramine production plant project report, the major raw materials for Clomipramine production include 3-chloroiminodibenzyl, Sodium Amide, and γ-dimethylaminopropyl Chloride.
Production Process of Clomipramine
The extensive Clomipramine production cost report consists of the following industrial production process:
- Production via 3-chloroiminodibenzyl: The production process of Clomipramine begins with dissolving 3-chloroiminodibenzyl in xylene, followed by the gradual addition of sodium amide under a nitrogen atmosphere, which forms a reactive sodium salt. This mixture is stirred at elevated temperature until ammonia evolution stops, which indicates completion of the reaction. Further, γ-dimethylaminopropyl chloride is prepared by liberating the free base from its hydrochloride salt using aqueous sodium hydroxide, then extracting and drying it with toluene. This reactive amine compound is added to the xylene solution containing the sodium salt, and the mixture is heated under reflux to promote coupling. After filtering out sodium chloride, the solvent is removed, and the residue is treated with dry hydrogen chloride gas to form the hydrochloride salt of Clomipramine. The final product is collected and purified through recrystallisation to obtain Clomipramine hydrochloride as the desired product.
Clomipramine is a dibenzazepine-derivative tricyclic antidepressant that is the 3-chloro analogue of imipramine and functions primarily as a potent serotonin and norepinephrine reuptake inhibitor. It appears as a white to off-white crystalline powder that is solid at room temperature and is odourless. The molecular formula of the compound is C19H23ClN2, and its molecular mass is 314.86 g/mol. The melting point of the compound ranges between 191.5-192 degree Celsius, and its boiling point is around 160-170 degree Celsius. It has a solubility of around 0.294 mg/L in water. The compound should be stored in tightly closed containers protected from light and moisture. Common side effects include sedation, drowsiness, dizziness, dry mouth, constipation, blurred vision, urinary retention, orthostatic hypotension, weight gain, sexual dysfunction, and increased sweating. The compound carries a black box warning for increased risk of suicidal thoughts and behaviours in children, adolescents, and young adults up to age 25, particularly during the initial treatment period.
